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Vasculogenesis	  and	  angiogenesis	  in	  tissue	  engineering	  Vasculogenesis	   is	   a	   de	   novo	   formation	   of	   blood	   vessels	   while	   angiogenesis	   describes	   a	  process	   of	   new	   blood	   vessel	   formation	   from	   pre-­‐existing	   vessels	   1.	   These	   processes	   enable	  vascularization	  of	  nearly	  all	  tissues	  in	  our	  body,	  with	  the	  notable	  exception	  of	  avascular	  cartilages,	  and	   this	   otherwise	   ubiquitous	   blood	   vessel	   network	   in	   tissues	   serves	   as	   an	   efficient	   transport	  system	   for	   distributing	   oxygen,	   nutrients	   and	   wastes	   to	   appropriate	   places.	   Passive	   diffusion	   of	  molecules	   alone	   is	   not	   sufficient	   for	   any	   substantial	   tissues	   exceeding	  ~200μm	   in	   thickness,	   and	  without	  thorough	  vascularization,	  necrosis	  takes	  place	  2.	  Hence,	  it	  is	  of	  paramount	  importance	  that	  any	   tissue	   engineering	   application	   includes	   careful	   considerations	   to	   strategies	   to	   either	   1)	  vascularize	  the	  engineered	  construct	  prior	  to	  implantation	  or	  2)	  design	  the	  constructs	  with	  careful	  choices	   on	   important	   parameters	   such	   as	   material	   compositions	   (haemocompatibility,	   soluble	  growth	  factors	  etc)	  and	  physical	  properties	  (ie.	  porosity)	  that	  will	  allow	  timely	  angiogenesis	  after	  implantation	  3.	  Unfortunately,	  vascularization	  in	  tissue	  engineering	  is	  still	  an	  outstanding	  challenge.	  Therefore,	  materials	  that	  readily	  induce	  angiogenesis	  and/or	  vasculogenesis	  in	  vitro	  and	  in	  vivo	  are	  sought-­‐after	  and	  will	  bring	  tissue	  and	  organ	  engineering	  one	  step	  closer	  to	  reality.	  	  	  	  
	  
Gelatin	  as	  a	  biomaterial	  	   Gelatin	   is	   an	   irreversibly	   denatured	   and	   hydrolyzed	   form	   of	   collagen,	   which	   is	   the	   most	  abundant	   protein	   in	   our	   body	   that	   makes	   up	   the	   majority	   of	   the	   extracellular	   matrix.	   As	   such,	  gelatin	   is	   known	   for	   its	   excellent	   biocompatibility,	   biodegradability,	   adhesiveness,	   and	   non-­‐immuno/antigenicity,	   in	  addition	   to	   the	  easy	  access	  and	  economic	  production	  when	  compared	   to	  
	   	   	  2	  
collagen	   4.	   Therefore,	   gelatin	   possesses	   numerous	   desirable	   characteristics	   for	   biological	  applications,	  and	  indeed	  it	  has	  been	  widely	  used	  as	  a	  preferred	  coating	  material	  for	  tissue	  culture	  plates,	   especially	   for	   primary	   endothelial	   cells	   that	   are	   especially	   difficult	   to	   culture	   in	   vitro	   5.	  However,	  the	  use	  of	  gelatin	  for	  tissue	  engineering	  application	  has	  been	  limited	  thus	  far	  mainly	  due	  to	  its	  low	  upper	  critical	  solution	  temperature	  below	  35°C,	  which	  makes	  it	  impossible	  to	  engineer	  a	  thermo-­‐stable	   gelatin	   construct	   for	   in	   vivo	   applications	   6.	   Accordingly,	   gelatin	   has	   been	   typically	  used	   as	   a	   component	   in	   composite	   materials,	   and	   there	   are	   very	   few	   studies	   employing	   purely	  gelatin-­‐based	   materials.	   Because	   of	   this	   limited	   use,	   understanding	   of	   gelatin	   as	   a	   biomaterial	  remains	  shallow.	  Therefore,	  we	  have	  developed	  and	  characterized	  modified	  gelatin	  by	  conjugating	  hydroxyphenyl	  propionic	  acids	  to	  the	  gelatin	  backbone,	  which	  allows	  for	   in	  situ	  crosslinking	  upon	  reaction	   with	   H2O2	   and	   horseradish	   peroxidase	   7.	   This	   design	   allows	   the	   fabrication	   of	   purely	  gelatin-­‐based	  hydrogels	   that	   are	   injectable	   and	   thermo-­‐stable.	   Its	   unknown	  biological	   effects	   and	  interactions	  with	  cells	  towards	  angiogenesis	  and	  vasculogenesis	  are	  the	  central	  topic	  of	  this	  study.	  	  	   	  	  	  	  	  
Mesenchymal	  stem	  cells	  in	  tissue	  engineering	  	   Mesenchymal	  stem	  cells	  (MSCs)	  are	  a	  subset	  of	  non-­‐hematopoeitic	  stem	  cells	   found	  in	  the	  bone	  marrow	  stroma,	  hence	  are	   also	   available	   in	   adults	   8.	   Since	   its	  discovery	   in	   the	  1980s,	  MSCs	  have	  been	  one	  of	  the	  most	  intensely	  studied	  type	  of	  stem	  cells	  as	  a	  promising	  cell	  source	  in	  tissue	  engineering.	   Previous	   studies	   revealed	   the	   multipotent	   differentiative	   capacity	   of	   MSCs	   ranging	  from	  well-­‐established	  differentiation	  into	  osteocytes,	  chondrocytes	  and	  adipocytes	  to	  more	  recently	  observed	  differentiation	  into	  various	  muscle	  cells,	  endothelial	  cells,	  and	  neurons	  (Figure	  A)	  8	  9.	   It	  was	  also	  shown	  that	  not	  only	  did	  MSCs	  differentiate	  down	  diverse	  lineages,	  they	  also	  came	  with	  a	  few	  other	  desirable	  traits	  such	  as	   immunomodulation,	  and	  	  “drugstore”-­‐like	  trophic	  activities	  that	  aid	  in	  regeneration	  10.	  Hence,	  we	  chose	  MSCs	  as	  a	  cell	  source	  for	  its	  multipotent	  nature	  as	  well	  as	  its	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regenerative	   properties	   to	   investigate	   their	   biological	   effects	   and	   interactions	   with	   in	   situ	  crosslinkable	  gelatin	  material.	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Synthesis	  of	  Gelatin-­‐Hydroxyphenyl	  Propionic	  Acid	  (GHPA)	  Synthesis	  of	  GHPA	  has	  been	  described	  previously	   7.	  Briefly,	  hydroxyphenyl	  propionic	  acid	  (HPA)	   was	   first	   activated	   with	   1-­‐ethyl-­‐3-­‐(3-­‐dimethylaminopropyl)-­‐carbodiimide	   (EDC),	   N-­‐hydroxysuccinimide	  (NHS)	  in	  a	  co-­‐solvent	  of	  water	  and	  DMF	  (volume	  ratio	  of	  3:	  2).	  The	  activated	  HPA	  solution	  was	   then	  added	   to	   the	  pre-­‐heated	  gelatin	  solution	  and	  stirred	  at	  40°C	   for	  24	  hours.	  The	   resulting	   solution	   was	   transferred	   into	   a	   dialysis	   bag	   (MWCO.	   3.5	   kDa),	   dialyzed	   against	  deionized	  water	  for	  3	  days,	  filtered,	  and	  lyophilized	  to	  obtain	  the	  GHPA	  conjugates	  (Figure	  1A).	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Characterization	  of	  Elastic/Storage	  Moduli	  (G’)	  of	  GHPA	  GHPA	   was	   dissolved	   in	   DMEM	   media	   (Invitrogen)	   at	   3-­‐7%	   (wt)	   and	   divided	   into	   two	  aliquots;	   one	  was	  mixed	  with	   horseradish	   peroxidase	   (HRP,	   Sigma)	   at	   the	   final	   concentration	   of	  2.5μg/ml,	   while	   the	   other	   aliquot	   was	   mixed	   with	   H2O2	   (Sigma)	   at	   the	   final	   concentrations	   of	  0.0025-­‐0.01%	  (w/v).	  Solutions	  can	  be	  loaded	  onto	  separate	  syringes,	  and	  a	  dual-­‐syringe	  applicator	  is	  used	  to	  evenly	  eject	  the	  two	  solutions,	  ensuring	  proper	  mixing	  and	  gelling	  (Figure	  1B).	  Storage	  moduli	   (G’)	   was	   measured	   in	   a	   parallel	   plate	   setting	   on	   a	   TA	   Instrument	   RA2000	   rheometer	   in	  oscillation	  mode	  with	  a	  frequency	  of	  1	  Hz	  and	  0.1%	  strain	  at	  37°C.	  	  
	  
In	  Vitro	  3D	  Culture	  of	  Mesenchymal	  Stem	  Cells	  (MSCs)	  in	  GHPA	  	  Wild	  type	  murine	  mesenchymal	  stem	  cells	  (MSCs,	  GIBCO)	  from	  passage	  12-­‐14	  or	  Flk-­‐1-­‐LacZ	  transgenic	  murine	  MSCs	  were	  used.	  GHPA	  and	  H2O2	  were	  dissolved	  in	  DMEM	  media	  at	  various	  %	  (w/v)	  as	  indicated,	  while	  a	  constant	  concentration	  of	  2.5μg/ml	  HRP	  was	  used	  in	  all	  conditions.	  Cells	  were	  added	  to	  the	  GHPA+HRP	  solution	  at	  the	  final	  concentration	  of	  106	  cells/ml.	  The	  same	  number	  of	  cells	  was	  seeded	  on	  tissue	  culture	  plate	  without	  GHPA	  gel	  to	  serve	  as	  a	  control.	  After	  GHPA	  gelled	  on	  the	  well	  plate,	  DMEM	  supplemented	  with	  10%	  FBS	  (Invitrogen)	  and	  1%	  penicillin-­‐streptomycin	  (Invitrogen)	  was	  added	  and	  media	  was	  changed	  every	  day	  over	  15	  days.	  	  
Cell	  viability	  assay:	  cell	  viability	  was	  measured	  at	  days	  1,	  7,	  and	  15	  post	  culture	  using	  5μM	  resazurin	   (Sigma).	   After	   4	   hours	   incubation	   of	   resazurin	   with	   cells,	   test	   culture	   media	   were	  transferred	  to	  a	  new	  96-­‐well	  plate	  for	  fluorescence	  readout	  at	  590nm	  using	  a	  TECAN	  M1000	  plate	  reader.	   On	   the	   same	   days,	   cells	   were	   also	   incubated	   in	   media	   containing	   1μM	   calcein	   AM	  (Invitrogen)	   and	   1μg/ml	   propidium	   iodide	   (Sigma)	   for	   15	   minutes	   then	   imaged	   by	   a	   Zeiss	   710	  confocal	  laser	  scanning	  microscope	  for	  identification	  of	  live/dead	  cells	  .	  Images	  were	  then	  z-­‐stacked	  using	  ImageJ	  (NIH)	  for	  presentation.	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MSC	  Delivery	  in	  GHPA	  Gels	  on	  Polyvinyl	  Alcohol	  (PVA)	  Scaffolds	  In	  Vivo	  
Subcutaneous	  implantation:	  Flk-­‐1-­‐LacZ	   transgenic	  murine	  MSCs	  were	  generously	  provided	  by	  Dr.	  Young	  lab	  as	  the	  expression	  of	  Flk-­‐1,	  a	  VEGFR-­‐2	  receptor	  in	  MSCs	  can	  be	  detected	  in	  situ	  by	  staining	  LacZ	   to	   verify	   their	   endothelial	   differentiation	   in	  vivo.	   GHPA	  and	  H2O2	  were	  dissolved	   in	  DMEM	  media	  at	  various	  %	  (w/v)	  as	  described	  above,	  while	  a	  constant	  concentration	  of	  2.5μg/ml	  HRP	   was	   used	   in	   all	   conditions.	   Flk1-­‐LacZ	   MSC	   (5x105)-­‐containing	   GHPA	   gel	   solutions	   in	   total	  volume	   of	   60μl	   were	   loaded	   on	   porous	   PVA	   scaffolds.	   The	   gel-­‐scaffold	   complexes	   were	   then	  subcutaneously	   implanted	   on	   the	   ventral	   side	   of	   C57/bl6	   mice	   for	   2	   weeks	   (Figure	   5A).	   As	   a	  control,	  porous	  PVA	  scaffolds	  loaded	  with	  non-­‐crosslinked	  GHPA	  gel	  solution	  containing	  Flk1-­‐LacZ	  MSCs	  were	  implanted.	  	  
Characterization	  of	  implanted	  scaffolds:	  At	  2	  weeks,	  mice	  were	  perfused	  under	  heavy,	  near	  lethal	  level	  of	  anesthesia.	  First,	  they	  were	  perfused	  with	  PBS	  containing	  0.1mg/ml	  heparin	  sulfate,	  followed	  by	  fluorescent	  microbeads	  (Invitrogen)	  for	  fluorescent	  micro-­‐angiography.	  Scaffolds	  were	  subsequently	  harvested	  and	  analyzed	  for	  mRNA	  expression	  by	  RT-­‐PCR,	  β-­‐galactosidase	  activity	  by	  x-­‐gal	   staining,	   angiogenesis	   by	   micro-­‐angiography	   and	   CD31	   staining,	   and	   the	   presence	   of	  remaining	   GHPA	   gel	   and	   general	   histological	   analysis	   by	   trichrome	   staining.	   Animal	   procedures	  were	  pre-­‐approved	  by	  and	  performed	  in	  accordance	  with	  Vanderbilt	  IACUC.	  	  
	  
Gene	  Expression	  Analysis	  via	  Quantitative	  Polymerase	  Chain	  Reaction	  (qRT-­‐PCR)	  Samples	  were	  homogenized	  in	  Trizol	  (Invitrogen),	  and	  RNA	  was	  collected	  using	  Rneasy	  kit	  (Qiagen).	  RNA	  concentration	  and	  260/280	  ratios	  were	  measured	  on	  a	  TECAN	  M1000	  plate	  reader.	  RNA	  was	   treated	  with	  DNAse	   to	  eliminate	  genomic	   contamination,	   and	   reverse-­‐transcribed	  using	  High	   Capacity	   cDNA	   Synthesis	   Kit	   (ABiosystems).	   SYBR	   Green	   PCR	   mix	   (Biorad)	   was	   used	   for	  quantitative	   PCR.	   Each	   sample	   containing	   at	   least	   40	   ng	   cDNA	   and	   500nM	   of	   each	   primer	   with	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annealing	  temperature	  at	  55°C	  was	  run	  in	  technical	  triplicates,	  followed	  by	  melting	  curve	  analysis.	  Raw	   data	   were	   analyzed	   using	   CFX	   Manager	   (Biorad),	   and	   biological	   replicates	   from	   different	  animals	   were	   combined	   11.	   GAPDH	   expression	   was	   used	   for	   normalization,	   where	   the	   GAPDH	  expression	   level	   divides	   each	   gene	   expression	   level,	   and	   this	   number	   is	   set	   to	   1	   for	   the	   control.	  Primers	  used	  in	  this	  study	  are	  listed	  in	  Table	  1.	  
	  
Histological/Immunohistochemical	  Staining	  
Tissue	  preparation:	  Samples	  were	  fixed	  in	  4%	  paraformaldehyde	  (PFA)	  for	  24	  hours	  at	  4°C,	  washed	  with	   PBS,	   and	   immersed	   in	   5%-­‐30%	   sucrose	   solution	   until	   samples	   sank.	   Samples	  were	  then	  embedded	   in	  optimal	  cutting	  temperature	  (TissueTek)	  compound	  and	  frozen	   in	  acetone	  and	  dry	  ice	  bath.	  15μm-­‐thick	  slices	  were	  obtained	  by	  cryosectioning.	  
Trichrome	  green	  staining:	  General	  histology	  and	   trichrome	  green	  staining	   for	   the	   left	  over	  parts	  of	  GHPA	  gels	  in	  the	  sections	  were	  performed	  by	  Vanderbilt	  Research	  Histology	  Core.	  	  	  
β-­‐galactosidase	   staining:	   Sample	   sections	   as	   well	   as	   positive	   and	   negative	   controls	   were	  fixed	  with	  4%	  PFA	  for	  10	  min	  at	  room	  temperature,	  washed	  with	  PBS,	  and	  incubated	  at	  37°C	  for	  2	  days	   in	   a	   solution	   containing	   the	   following:	   27mM	  NaH2PO4,	   73mM	  Na2HPO4,	   2mM	  MgCl2,	   2mM	  EGTA,	   1μg/ml	  NP40,	   5mM	  K4[Fe(CN)6],	   5mM	  K3[Fe(CN)6],	   and	   1mg/ml	   x-­‐gal	   (all	   chemicals	   from	  Sigma).	  Slides	  were	  then	  washed	  with	  dH2O	  and	  mounted.	  
CD31	  staining:	  Sample	  sections	  as	  well	  as	  a	  positive	  control	  was	  fixed	  with	  4%	  PFA	  for	  10	  min	  at	  room	  temperature;	  washed	  with	  PBS,	  blocked	  with	  10%	  goat	  serum	  and	  1%	  bovine	  serum	  albumin	  overnight	   at	   4°C;	  washed	  with	  PBS;	   and	   incubated	  with	   goat	   anti-­‐mouse	  CD31	   antibody	  (eBioscience)	   overnight	   at	   4°C,	   followed	   by	   incubation	  with	   Dylight594-­‐conjugated	   anti-­‐goat	   IgG	  (Jackson	  Lab).	  Sections	  were	  then	  counter-­‐stained	  with	  DAPI	  and	  mounted	  for	  imaging.	  	  
Imaging:	   Bright-­‐field	   microscopy	   for	   β-­‐galactosidase	   and	   trichrome	   green	   stain	   was	  performed	  on	  a	  Nikon	  Eclipse	  Ti	  scope,	  and	  fluorescence	  images	  for	  CD31	  and	  micro-­‐angiography	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were	   acquired	   using	   a	   Zeiss	   710	   confocal	   laser	   microscope.	   ImageJ	   was	   used	   for	   z-­‐stacking	  fluorescence	  images.	  	  	  
	  
Statistical	  Analysis	  	  Results	  are	  presented	  as	  means	  ±	  standard	  deviation	  (SD)	  or	  standard	  error	  mean	  (SEM)	  as	  indicated.	  Comparisons	  among	  different	  conditions	  were	  performed	  using	  an	  unpaired	  Student’s	  t-­‐test.	   For	   all	   statistics,	   p	   <	   0.05	   was	   considered	   statistically	   significant,	   and	   such	   significance	   is	  indicated	  where	  appropriate.	  	  	  
Results	  	  
Synthesis	  and	  Characterization	  of	  Gelatin-­‐Hydroxyphenyl	  Propionic	  Acid	  (GHPA)	  	  	   Hydrogels	   were	   successfully	   produced	   from	   hydroxyphenyl	   propionic	   acid-­‐conjugated	  gelatin	  that	  underwent	  in	  situ	  oxidative	  crosslinking	  among	  the	  phenolic	  moieties	  catalyzed	  by	  H2O2	  and	  HRP	   (Figure	   1).	   	   As	   seen	   in	  Figure	   1B,	   two	  GHPA	   solutions	   are	   prepared	   in	   order	   to	   avoid	  premature	  gelation	  where	  one	  GHPA	  solution	  contains	  HRP	  while	   the	  other	  GHPA	  contains	  H2O2.	  HRP	  or	  H2O2-­‐containing	  GHPA	  solutions	  are	   loaded	   in	  separate	  syringes,	  and	  the	  solutions	  can	  be	  injected	   or	   sprayed	   for	   in	   situ	   cross-­‐linking	   for	   various	   applications7.	   For	   cell	   experiments,	   cells	  were	  suspended	  in	  HRP-­‐containing	  GHPA	  in	  order	  to	  minimize	  cytotoxicity	  due	  to	  H2O2	  exposure.	  	  	   Mechanical	   properties	   were	   characterized	   without	   cells	   at	   37°C.	   All	   test	   materials	  underwent	   gelation	  within	   20	   seconds.	   The	   results	   from	  measuring	   storage	  moduli	   (G’)	   of	   GHPA	  gels	  with	  varying	  GHPA	  and	  H2O2	  concentrations	  are	  shown	  in	  Figure	  2.	  Overall,	  crosslinked	  GHPA	  gels	  exhibited	  storage	  moduli	  ranging	  from	  ~100	  Pa	  to	  ~2500	  Pa	  which	  are	  typical	  of	  soft	  hydrogels.	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Figure	   1.	   (A)	   Synthesis	   of	  gelatin-­‐hydroxyphenyl	   propionic	   acid	   (GHPA).	   (B)	  Rapid	  gelation	  of	  GHPA	  by	  
H2O2	   and	   horseradish	   peroxidase	   (HRP)-­‐catalyzed	   oxidative	   crosslinking.	   Bottom	   right	   image	   shows	   a	  
dual-­‐syringe	   system	   for	   cell-­‐containing	  GHPA	   injections	   for	   in	   situ	   crosslinking,	   and	   this	   system	   can	  be	  
used	  for	  injection	  or	  spraying.	  	  	  
Figure	   2.	   Storage	   moduli	   (G’)	   of	   crosslinked	   GHPA	   gels	   with	   varying	   concentrations	   of	   GHPA	  
[%w/v]	  and	  H2O2	  [%w/v]	  were	  measured	  using	  a	  rheometer	  with	  N=3	  and	  error	  bars	  =	  ±1	  SEM.	  
The	  compositions	  indicated	  with	  arrows	  were	  used	  for	  the	  following	  biological	  experiments.	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An	   increase	   in	   either	   gelatin	   or	   hydrogen	   peroxide	   concentration	   resulted	   in	   an	   increase	   in	   the	  storage	  modulus	  as	  expected.	  Maximum	  GHPA	  concentration	  used	  was	  at	  7%	  (w/v)	  due	  to	  the	  high	  viscosity.	   We	   chose	   to	   perform	   biological	   experiments	   with	   the	   three	   different	   formulations	  indicated	  with	  arrows	   in	  Figure	   2.	  We	  mostly	   chose	   formulations	  with	  high	  moduli	   as	  hydrogels	  with	  high	  moduli	  have	  better	  hydrogel	  stability	  in	  vivo.	  	  
	  
In	  Vitro	  3D	  Culture	  of	  Mesenchymal	  Stem	  Cells	  (MSCs)	  in	  GHPA	  	  	   Using	   the	   aforementioned	   dual-­‐syringe	   system	   (Figure	   1B),	   GHPA	   solutions	   containing	  MSCs,	   HRP,	   and	   H2O2	  were	   mixed	   upon	   injection	   and	   gelled	   in	   a	   24	   well	   plate	   of	   tissue	   culture	  polystyrene	   (TCPS)	   for	   in	   vitro	   3D	   culture	   over	   15	   days.	   Reduction	   of	   resazurin	  was	   used	   as	   an	  indicator	   of	   live	  metabolic	   cells,	   and	   it	  was	  measured	  on	  days	  1,	   7,	   and	  15.	  The	   same	  number	  of	  MSCs	   cultured	   on	   TCPS	   without	   GHPA	   served	   as	   a	   control	   for	   100%	   cell	   viability	   (Figure	   3A).	  Among	   the	   different	   GHPA	   compositions	   there	   was	   no	   statistically	   difference	   in	   cell	   viability,	  although	  the	  condition	  with	  the	  highest	  GHPA	  and	  H2O2	  contents	  (7%:0.01%)	  appeared	  to	  slightly	  lag	   behind	   the	   others.	   The	   higher	   concentration	   of	   hydrogen	   peroxide,	   a	   known	   cytotoxic	   agent,	  may	  account	   for	   the	   lower	  cell	  viability	  of	  7%:0.01%	  condition.	  Similarly,	   initial	  MSC	  exposure	   to	  the	  remaining	  unreacted	  H2O2	  could	  be	  responsible	   for	   the	   initially	   low	  cell	  viability	   for	  all	  GHPA	  conditions.	  Additionally,	  cell	  viability	  of	  MSCs	  in	  GHPA	  gels	  may	  have	  been	  limited	  by	  slow	  diffusion	  of	   nutrients	   and	   wastes	   through	   the	   crosslinked	   gelatin	   network,	   especially	   in	   a	   static	   culture	  condition.	  Despite	  its	  shortcomings,	  viability	  of	  MSCs	  in	  GHPA	  gels	  greatly	  improved	  to	  above	  70%	  for	  all	  GHPA	  conditions	  on	  day	  15	  after	  a	  poor	  initial	  survival	  rate	  of	  ~20%.	  	  Continuous	  improvement	  in	  cell	  viability	  of	  MSCs	  upon	  3D	  GHPA	  culture	  over	  time	  was	  also	  evident	   in	   live/dead	   imaging	   (Figure	   3B).	   On	   day	   1,	   all	   cells	   exhibited	   round	  morphology	   with	  numerous	  dead	  cells	  along	  with	  live	  cells.	  On	  day	  7,	  many	  elongated	  MSCs	  were	  observed,	  and	  far	  fewer	  dead	  cells	  were	  present.	  Lastly	  on	  day	  15,	  most	  cells	  had	  elongated,	  and	  they	  were	  often	  seen	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Figure	  3.	  (A)	  In	  vitro	  cell	  viability	  of	  MSCs	  encapsulated	  in	  crosslinked	  GHPA	  gels	  on	  days	  1,	  7,	  and	  
15	  compared	  to	  MSCs	  on	  tissue	  culture	  polystyrene	  (TCPS)	  by	  resazurin	  reduction	  with	  N=3	  and	  
error	   bars	   =	   ±1	   SD.	   X%:Y%	   denotes	   X	   %w/v	   gelatin	   and	   Y	   %w/v	   H2O2.	   (B)	   Confocal	   images	   of	  
Live/Dead	  staining	  of	  3D	  MSC	  culture	  in	  GHPA	  on	  days	  1,	  7,	  and	  15.	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  forming	  branched	  tube	  networks,	  while	  the	  top	  surface	  of	  GHPA	  gel	  was	  completely	  covered	  by	  a	  layer	  of	  MSCs	  (data	  not	  shown).	  Overall,	  crosslinked	  GHPA	  gels	  supported	  robust	  MSC	  proliferation	  within	  and	  on	  the	  surface,	  and	  the	  changes	  in	  cell	  morphology	  and	  organization	  showed	  active	  cell-­‐material	  interactions	  towards	  vasculogenesis.	  	  
	  
In	  Vitro	  MSC	  Differentiation	  to	  Endothelial	  Lineage	  in	  GHPA	  	   Since	   the	   unusual	   organization	   of	   branching	   tube	   networks	   was	   observed	   in	   MSCs	  encapsulated	   in	   GHPA	   gels	   on	   day	   15	   (Figure	   3B),	   we	   tested	   if	   this	   material	   promotes	   MSC	  differentiation	  to	  a	  certain	  lineage	  upon	  encapsulation	  in	  vitro.	  Again	  MSCs	  were	  encapsulated	  and	  cultured	   in	  GHPA	  gels	   for	  15	  days,	  and	  their	  RNA	  was	  collected.	   Initial	  differentiation	  survey	  was	  done	   by	   RT-­‐PCR	   for	   myogenic	   (MyoD),	   cardiac	   (GATA-­‐4),	   neural	   (Nfl),	   and	   endothelial	   (Flk-­‐1)	  markers,	  and	   the	  PCR	  products	  were	  run	  on	  an	  agarose	  gel	   for	  visualization.	  Among	   the	  markers	  investigated,	   only	   Flk-­‐1	   showed	   a	   positive	   expression	   (data	   not	   shown),	   hence	   we	   decided	   to	  further	  characterize	  potential	  MSC	  differentiation	  into	  an	  endothelial	  lineage	  by	  qRT-­‐PCR	  for	  CD31	  and	  Flk-­‐1,	   and	   the	  results	  are	  shown	   in	  Figure	   4A.	  For	  both	  endothelial	  markers,	  MSCs	  grown	   in	  GHPA	   gels	   showed	   statistically	   significant	   up-­‐regulation	   of	  CD31	   (>5	   folds)	   and	  Flk-­‐1	   (≈	   4	   folds)	  expression	  in	  all	  GHPA	  conditions	  in	  comparison	  to	  MSCs	  on	  TCPS	  (p	  <	  0.05).	  	  	   To	  test	   if	  such	  increase	  in	  the	  Flk-­‐1	  expression	  at	  the	  gene	  level	  was	  reflected	  at	  the	  protein	  level,	   we	   used	   Flk-­‐1-­‐LacZ	   transgenic	   murine	   MSCs.	   These	   cells	   were	   cultivated	   in	   an	   identical	  condition,	  and	  on	  day	  15	  LacZ	  expression	  was	  assayed	  at	  both	  the	  gene	  and	  protein	   levels	  where	  positive	  LacZ	  expression	  would	  imply	  positive	  expression	  for	  Flk-­‐1	  (Figure	  4B).	  Interestingly,	  the	  MSCs	   cultured	   in	   5%:0.005%	   condition	   were	   positive	   for	   LacZ	   expression	   at	   both	   the	   gene	   and	  protein	   levels.	   Of	   note,	   these	   transgenic	   cells	   were	   noticeably	   slower	   in	   growth	   and	   elongation	  while	   encapsulated	   in	   GHPA	   gels	   compared	   to	   the	   wild	   type	   MSC.	   In	   fact,	   it	   was	   evident	   from	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cryosectioned	  samples	  that	  Flk-­‐1-­‐LacZ	  MSCs	  were	  mainly	  located	  near	  the	  surface,	  and	  fewer	  cells	  were	  observed	  throughout	  the	  gel,	  possibly	  indicating	  difficulties	  in	  surviving	  in	  GHPA	  gels	  for	  the	  transgenic	  cells.	  Hence	  it	  may	  require	  additional	  culture	  time	  for	  Flk-­‐1-­‐LacZ	  MSCs	  to	  reach	  the	  same	  extent	  of	  proliferation	  and	  differentiation	  in	  GHPA	  gels	  compared	  to	  the	  wild	  type	  MSCs.	  	  	  
	  
	  
In	  Vivo	  Subcutaneous	  Implantation	  of	  MSC-­‐containing	  GHPA	  Gels	  	   In	  order	  to	  confirm	  the	  effect	  of	  GHPA	  gels	  on	  MSC	  differentiation	  towards	  the	  endothelial	  lineage	  in	  vitro,	  we	  investigated	  the	  potential	  pro-­‐angiogenic	  effect	  of	  MSC-­‐delivering	  GHPA	  gels	  in	  
vivo.	   Flk-­‐1-­‐LacZ	   MSC-­‐containing	   GHPA	   gel	   was	   injected	   into	   porous,	   non-­‐biodegradable	   PVA	  sponges,	  and	  the	  gel-­‐PVA	  sponge	  complexes	  were	  implanted	  into	  ventral	  subcutaneous	  regions	  in	  the	  wild	  type	  C57Bl/6	  mice	  for	  2	  weeks	  (Figure	  5A).	  Because	  	  multiple	  implantations	  are	  possible	  in	  each	  mouse,	  this	  model	  enabled	  better	  control	  in	  biological	  variability	  among	  the	  mice	  and	  better	  comparisons	   among	   the	   test	   conditions,	   and	   reduced	   the	   number	   of	   the	   animals	   required.	   Four	  different	   gel-­‐PVA	   scaffolds	   were	   implanted	   in	   each	   mouse:	   a	   control	   containing	   MSCs	   in	   non-­‐crosslinked	   GHPA	   and	   three	   gel-­‐scaffolds	   carrying	   MSCs	   in	   different	   crosslinked	   GHPA	   gel	  formulations	  (5%:0.005%,	  7%:0.005%,	  and	  7%:0.01%).	  PVA	  scaffolds	  were	  necessary	  to	  track	  the	  
Figure	   4.	   (A)	  MSC	  expression	   for	  endothelial	   cell	  markers	  CD31	   and	  Flk-­‐1	  were	  determined	   from	  
mRNA	   after	   15	   days	   of	   culture	   in	   GHPA	   gels	   by	   qRT-­‐PCR	   with	   N=3	   and	   error	   bars	   =	   ±1	   SEM.	   *	  
indicates	   p<0.05	   in	   comparison	   to	   control	  MSCs	  on	   tissue	   culture	   plate.	   (B)	  Flk1-­‐LacZ	   transgenic	  
MSCs	  were	  cultured	  in	  GHPA	  gels	  for	  15	  days	  and	  assayed	  for	  LacZ	  mRNA	  expression	  by	  qRT-­‐PCR	  
and	  protein	  expression	  by	  β-­‐galactosidase	  stain	  on	  day	  15.	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delivered	   cells	   and	   GHPA,	   as	   gelatin	   is	   known	   for	   fast	   in	   vivo	   degradation	   by	   host	   matrix	  metalloproteinase	   (MMPs)	   12.	   Similarly,	  Flk-­‐1-­‐LacZ	   transgenic	  MSCs	  were	   used	   to	   distinguish	   the	  implanted	  cells	  from	  host	  cells	  and	  provided	  a	  convenient	  reporter	  system	  where	  their	  phenotypic	  change	  into	  an	  endothelial	  lineage	  is	  indicated	  by	  positive	  LacZ	  expression.	  	  	   After	   2	   weeks	   of	   implantation,	   the	   scaffolds	   were	   harvested	   and	   sectioned	   for	   various	  analyses.	   Trichrome	   green	   staining	   was	   used	   to	   visualize	   collagen/GHPA	   (green-­‐light	   blue),	  cytoplasm	  of	  various	  cell	  types	  (purple-­‐red),	  and	  erythrocytes	  (small	  pink	  rings	  due	  to	  their	  lack	  of	  nuclei)	  (Figure	  5B).	  In	  all	  conditions,	  there	  was	  robust	  leukocyte	  infiltration	  indicated	  by	  extensive	  distribution	  of	  round	  purple-­‐red	  cells	  slightly	  bigger	  than	  erythrocytes	  which	  are	  small	  pink	  rings	  throughout	  the	  scaffolds,	  and	  erythrocytes	  were	  often	  observed	  as	  well.	  However,	  there	  were	  two	  significant	   differences	   among	   the	   conditions:	   1)	   more	   collagen	   and/or	   gelatin	   was	   present	   in	  conditions	  with	  higher	  GHPA	  and	  hydrogen	  peroxide	  contents,	  and	  sometimes	  chunks	  of	  remaining	  GHPA	   with	   few	   cells	   were	   observed	   in	   crosslinked	   GHPA	   conditions	   (e.g.,	   left	   side	   in	   the	   upper	  image	  for	  7%:0.01%	  condition),	  and	  2)	  crosslinked	  GHPA	  conditions	  frequently	  exhibited	  vascular	  capillaries	   throughout	   the	   scaffolds	   with	   organized	   branches	   of	   cells	   extending	   few	   hundred	  microns	  that	  contained	  erythrocytes.	  However,	  such	  organization	  was	  largely	  lacking	  in	  the	  control.	  Additionally,	  it	  was	  evident	  that	  there	  was	  no	  giant	  foam	  cells	  or	  fibrous	  capsule	  formation	  around	  the	  chunks	  of	  crosslinked	  GHPA.	  	  	  	  	   Sections	  were	   also	   stained	   for	   β-­‐galactosidase	   activity	   to	   reveal	   Flk-­‐1-­‐LacZ	  positive	  MSCs	  that	  were	   implanted	   (Figure	   5C).	   It	   is	   clear	   that	   all	   three	   crosslinked	   GHPA	   conditions	   retained	  many	   implanted	  MSCs	   that	  were	  positive	   for	  Flk-­‐1-­‐LacZ	  (blue)	  staining	   throughout	   the	  scaffolds	   ,	  indicating	  MSC	  differentiation	   into	  an	  endothelial	   lineage	   in	  vivo.	  For	   the	  control	  condition,	  Flk-­‐1-­‐LacZ-­‐positive	  MSCs	  were	  mostly	  observed	  near	   the	   surface	  of	   the	  PVA	  scaffolds,	   and	   far	   fewer	   in	  quantity.	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In	  Vivo	  Pro-­‐Angiogenic	  Effect	  of	  MSC	  Delivery	  in	  GHPA	  
	   In	   order	   to	   visualize	   the	   functional	   neovasculature	   in	   the	   implanted	   PVA	   scaffolds,	   mice	  were	   perfused	   with	   saline	   containing	   fluorescent	   microbeads	   for	   micro-­‐angiography	   before	  harvesting	  the	  scaffolds.	  The	  resulting	  micro-­‐angiograms	  from	  the	  surface	  and	  cross-­‐sections	  of	  the	  scaffolds	   for	   each	   condition	   are	   shown	   in	   the	   upper	   panel	   of	  Figure	   6.	   Note	   that	   all	   angiograms	  
Figure	   5.	   (A)	   Schematic	  of	   In	  vivo	  experiment	  where	  Flk-­‐1-­‐LacZ	  MSCs-­‐containing	  GHPA	  was	  
injected	  into	  and	  crosslinked	  within	  a	  porous	  PVA	  scaffold	  for	  a	  murine	  ventral	  subcutaneous	  
implantation.	   (B)	   Trichrome	   green	   staining	   of	   cross-­‐sections	   of	   scaffolds	   at	   2	   weeks	   post	  
implantation	   where	   cytoplasm	   is	   stained	   red,	   erythrocytes	   pink	   and	   collagen/GHPA	   gels	  
blue/green.	  (C)	  β-­‐galactosidase	  staining	  shows	  that	  delivered	  Flk-­‐1-­‐LacZ	  MSCs	  were	  retained	  
and	  became	  Flk1-­‐LacZ+	  post	  2-­‐week	  implantation	  in	  crosslinked	  GHPA	  conditions.	  The	  boxes	  
indicate	  Flk1-­‐LacZ+	  cell-­‐containing	  areas.	  (B-­‐C)	  Upper	   images	  with	  a	  scale	  bar	  =	  200μm,	  and	  
lower	  images	  with	  a	  scale	  bar	  =	  50μm.	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shown	   are	   from	   the	   same	   mouse.	   Neovasculature	   in	   implanted	   scaffolds	   are	   different	   from	   the	  vasculature	   in	   the	   native	   host	   tissues	   around	   the	   implantation	   site	   in	   two	   important	   ways:	   1)	  implanted	  scaffolds	  are	  not	  as	  profusely	  vascularized	  as	  the	  ones	  surrounding	  the	  host	  tissues,	  and	  2)	  neovasculature	  in/on	  scaffolds	  are	  mostly	  tortuous	  and	  branching	  in	  shape	  while	  the	  vasculature	  in	   the	   neighboring	   tissues	   exhibits	  well-­‐organized	   blood	   vessels	   running	   straight	   and	   parallel	   to	  each	  other	  (data	  not	  shown).	  Across	  all	  conditions,	  the	  surfaces	  of	  the	  implanted	  scaffolds	  showed	  well-­‐connected	  and	  well-­‐developed	  functional	  vasculature	  where	  smaller	  capillaries	  with	  diameters	  <	  10μm	  sprouted	  from	  larger	  arterioles	  that	  were	  20-­‐30μm	  in	  diameters.	  The	  control	  scaffold	  also	  formed	   a	   considerable	   amount	   of	   neovasculature	   on	   its	   surface.	   However,	   the	   crosslinked	   GHPA	  conditions	  especially	  in	  the	  7%:0.01%	  condition	  showed	  a	  drastic	  enhancement	  in	  angiogenesis	  on	  the	   surface	   compared	   to	   the	   control..	   On	   the	   other	   hand,	   the	   micro-­‐angiograms	   from	   the	   cross-­‐sections	  of	  the	  scaffolds	  reveal	  an	  even	  more	  stark	  difference	  between	  the	  control	  and	  crosslinked	  GHPA	   conditions,	  where	   the	   control	   condition	   showed	   a	   limited	   degree	   of	   neovasculature	   at	   the	  perimeter	   of	   the	   scaffold	   while	   the	   crosslinked	   GHPA	   gels	   supported	   robust	   angiogenesis	  throughout	  the	  cross-­‐sections.	  Understandably,	  there	  is	  a	  lesser	  amount	  of	  vasculature	  seen	  on	  the	  cross-­‐sections	   than	  on	   the	   surfaces	  due	   to	   limited	  access,	   and	  blood	  vessels	   exhibited	  even	  more	  tortuosity	  within	  the	  scaffold	  likely	  due	  to	  the	  physical	  obstacles	  in	  the	  form	  of	  non-­‐biodegradable	  PVA	  scaffold.	  	  	   Blood	  vessel	  formation	  was	  further	  confirmed	  by	  CD31	  staining	  of	  the	  cross-­‐sections	  of	  the	  scaffolds	  as	  shown	  in	  the	  bottom	  panel	  of	  Figure	  6.	  In	  all	  conditions,	  there	  were	  two	  types	  of	  CD31+	  cells.	   The	   first	   type	  was	   individual	   cells	  with	   a	   circular	  nucleus	   and	  CD31	  expression	   around	   the	  nuclei,	   likely	   indicating	   infiltrating	   leukocytes	   13,	   and	   the	   second	   type	   exhibited	   elongated	   nuclei	  and	   CD31	   expression	   with	   tubular	   structures	   spanning	   ~50μm,	   indicating	   blood	   vessels.	   CD31	  staining	  of	  the	  control	  section	  is	  in	  agreement	  with	  the	  micro-­‐angiogram	  where	  the	  vasculature	  is	  mostly	   formed	   near	   the	   surface	   (the	   right	   side	   of	   the	   image),	   with	   few	   CD31+	   infiltrating	   single	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cells.	   In	   contrast,	   all	   three	   crosslinked	   GHPA	   conditions	   showed	   numerous	   CD31+	   cells	   both	   as	  single	   cells	   and	   in	   tubular	   structures,	   indicative	   of	   blood	   vessels.	   In	   5%:0.005%	   and	   7%:0.01%	  conditions,	  capillaries	  about	  10μm	  in	  diameter	  were	  dominant	  while	  the	  7%:0.005%	  condition	  also	  exhibited	  newly	  forming	  tubes	  with	  diameters	  in	  the	  4~5μm	  range.	  Taken	  together,	  the	  angiograms	  and	   CD31	   staining	   showed	   functional,	   perfusable	   neovasculature	   formation	   throughout	   the	  implanted	  scaffolds	  for	  crosslinked	  GHPA	  conditions,	  while	  only	  a	  limited	  degree	  of	  	  vascularization	  was	  seen	  near	  the	  surface	  for	  the	  control	  scaffolds.	  	  
	  	   	  
	   	  
	  
Figure	   6.	  Upper	   panel	   shows	  micro-­‐angiograms	   from	   the	   scaffolds	   at	   2	  weeks	   post	   implantation	  
acquired	  by	  perfusing	  mice	  with	  fluorescent	  beads.	  Representative	   images	  from	  the	  outer	  surface	  
and	  cross-­‐sections	  are	  shown.	  White	  dotted	  line	  marks	  the	  boundary	  of	  the	  scaffold.	  Bottom	  panel	  
shows	  CD31	  and	  nuclei	  stained	  cross-­‐sections	  of	  explanted	  scaffolds.	  All	   images	  were	  acquired	  by	  
confocal	  microscopy.	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In	  Vivo	  Gene	  Expression	  in	  GHPA	  Gels	  Delivering	  MSCs	  
	   RNA	   collected	   from	   the	   harvested	   scaffolds	   was	   analyzed	   by	   qRT-­‐PCR	   to	   quantitatively	  analyze	  gene	  expression.	  Both	  the	  early	  (Flk-­‐1,	  VE-­‐cadherin,	  CD31)	  and	  mature	  stage	  markers	  (vWF)	  of	   angiogenesis	   were	   analyzed,	   and	   the	   results	   are	   shown	   in	   Figure	   7A.	   Angiogenesis	   markers,	  especially	   those	   for	   the	   early	   stage,	   were	   significantly	   up-­‐regulated	   in	   the	   crosslinked	   GHPA	  conditions	  compared	  to	  the	  control.	  For	  Flk-­‐1,	  crosslinked	  GHPA	  conditions	  showed	  approximately	  1-­‐,	  2-­‐,	  3-­‐fold	   increases	   in	  expression	  for	  5%:0.005%,	  7%:0.005%,	  and	  7%:0.01%	  respectively.	  For	  
VE-­‐cadherin,	   crosslinked	   GHPA	   conditions	   showed	   approximately	   1-­‐,	   4-­‐,	   and	   12-­‐fold	   increases	   in	  expression	   for	   5%:0.005%,	   7%:0.005%,	   and	   7%:0.01%	   respectively.	   In	   a	   similar	   trend,	   CD31	  expression	   showed	   1-­‐,	   1-­‐,	   and	   3-­‐fold	   increases	   for	   5%:0.005%,	   7%:0.005%,	   and	   7%:0.01%,	  respectively.	  For	  these	  early	  angiogenesis	  markers	  (Flk-­‐1,	  VE-­‐cadherin	  and	  CD31),	  there	  was	  a	  clear	  positive	   correlation	   between	   the	   marker	   expression	   and	   the	   GHPA	   content/crosslinking	   degree.	  However,	   this	   trend	   was	   not	   observed	   for	   the	   late	   stage	   angiogenesis	   marker,	   vWF,	   where	   all	  crosslinked	  GHPA	  conditions	  had	  about	  60%	  increase	  in	  comparison	  to	  the	  control	  condition.	  This	  may	  be	  due	  to	  the	  fact	  that	  vWF	  expression	  varies	  depending	  on	  the	  organ	  and	  blood	  vessel	  type,	  and	   is	   rarely	   observed	   in	   small	   capillaries	   or	   neovasculature	   14.	   Collectively,	   these	   results	  demonstrate	   that	   overall	   there	   were	   significant	   increases	   in	   angiogenesis	   in	   crosslinked	   GHPA	  conditions,	  and	  that	  such	  increases	  were	  even	  more	  pronounced	  in	  conditions	  with	  higher	  amounts	  of	  GHPA	  and	  crosslinking.	  	   We	  also	  measured	  the	  expression	  of	  two	  markers	  (iNOS	  and	  MRC1)	  that	  represent	  the	  host	  macrophage	  response	  to	   the	   implants	  (Figure	   7B).	  Both	   iNOS	  and	  MRC1	  are	  macrophage-­‐specific	  markers	   with	   iNOS	   expression	   associated	   with	   a	   classically-­‐activated/inflammatory	   macrophage	  phenotype	  while	  MRC1	  expression	  is	  closely	  associated	  with	  an	  alternatively-­‐activated/reparative	  macrophage	  phenotype	  15.	  For	  iNOS	  expression,	  the	  5%:0.005%	  showed	  a	  50%	  increase	  compared	  to	   the	   control,	   however,	   iNOS	   expression	   for	   7%:0.005%	   was	   about	   the	   same,	   and	   7%:0.01%	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showed	   a	   50%	   decrease	   in	   comparison	   to	   the	   control.	   For	   MRC1,	   there	   was	   again	   the	  GHPA/crosslinking-­‐dependent	  trend	  of	  increasing	  expression	  with	  7%:0.01%	  condition	  having	  the	  highest	   level	   of	   MRC1	   expression	   at	   1.9-­‐fold	   that	   of	   the	   control.	   These	   results	   indicate	   that	   the	  7%:0.01%	  condition	  invoked	  a	  favorable	  response	  from	  the	  host	  macrophages	  with	  reduced	  iNOS	  expression	  and	  increased	  MRC1	  expression.	  	  
	  
	   	  
Figure	  7.	  2	  weeks	  post	  implantation,	  explanted	  scaffolds	  were	  assayed	  for	  gene	  expression	  of	  (A)	  
angiogenesis/	  endothelial	  cell	  markers	  and	  (B)	  macrophage	  markers	  by	  qRT-­‐PCR	  with	  N=4	  and	  error	  
bars	  =	  ±1	  SEM.	  	  =	  ±1	  SEM.	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Table	  1.	  List	  of	  primers.	  
Genes	   Forward	  Primer	   Reverse	  Primer	  β-­‐Actin	   TCGTGCGTGACATCAAAGAG	   TGGACAGTGAGGCCAGGATG	  CD31	   TCCCTGGGAGGTCGTCCAT	   GAACAAGGCAGCGGGGTTTA	  Flk-­‐1	   GAGAGCAAGGCGCTGCTAGC	   GACAGAGGCGATGAATGGTG	  GAPDH	   TGAAGCAGGCATCTGAGGG	   CGAAGGTGGAAGAGTGGGAG	  iNOS	   CCAAGCCCTCACCTACTTCC	   CTCTGAGGGCTGACACAAGG	  LacZ	   GCGTTAACTCGGCGTTTCAT	   GCGCTCAGGTCAAATTCAGAC	  MRC-­‐1	   TTGTGGTGAGCTGAAAGGTG	   GTGGATTGTCTTGTGG	  VE-­‐cadherin	   TCCTCTGCATCCTCACTATCACA	   GTAAGTGACCAACTGCTCGTGAAT	  vWF	   GCTTGAACTGTTTGACGGAGAGG	   TGACCCAGCAGCAGGATGAC	  
	  
Discussion	  	   The	   primary	   purpose	   of	   this	   study	   was	   to	   evaluate	   in	   situ	   crosslinkable	   gelatin	   as	   an	  advanced	  biomaterial	   template	   to	  promote	  vasculogenesis	  when	  used	  to	  deliver	  MSCs.	  With	  wide	  availability,	  economic	  production,	  excellent	  biocompatibility,	  and	  non-­‐antigenicity,	  gelatin	  is	  worth	  serious	  consideration	  as	  a	  highly	  functional	  biomaterial.	  However,	  its	  use	  has	  been	  severely	  limited	  due	   to	   its	   low	   upper	   critical	   solution	   temperature	   below	   35°C	   6.	   Conjugation	   of	   hydroxyphenyl	  propionic	   acid	   to	   the	   gelatin	   backbone	   enables	   rapid	   H2O2-­‐	   and	   horseradish	   peroxide	   (HRP)-­‐mediated	  crosslinking,	  and	  such	  modification	  allows	  the	  use	  of	  gelatin	  as	  a	  thermo-­‐stable	  hydrogel	  for	  biomedical	   applications	  at	   the	  body	   temperature	  of	  37°C.	  As	  expected,	   crosslinked	  GHPA	  gels	  exhibited	  storage	  moduli	  (G’)	  typical	  of	  soft	  hydrogels,	  and	  all	  test	  conditions	  gelled	  rapidly	  under	  20	   seconds	   at	   37°C.	   Its	   rapid	   gelation	   property	   and	   injectability	   with	   relatively	   non-­‐harsh	  crosslinking	   conditions	   make	   GHPA	   an	   excellent	   biomaterial	   platform	   for	   minimally	   invasive	  biomedical	  applications.	  	  As	   a	   collagen-­‐derived	  material,	   gelatin	   possesses	   numerous	   cell	   binding	   recognition	   sites	  with	  the	  RGD	  sequence	  being	  the	  most	  well-­‐known	  and	  prevalent	  site	  16.	  This	  is	  a	  crucial	  advantage	  of	   collagen-­‐	   or	   gelatin-­‐based	   materials	   over	   synthetic	   ones	   (ie.	   Poly(ethylene	   glycol)	   hydrogels)	  whose	   cell	   attachment	   and	   viability	   are	   often	   insufficient	   17	   18.	   Most	   anchorage-­‐dependent	   cells	  require	  attachment	  and	  spreading	  on	  a	  culture	  substrate	  for	  survival	  and	  proliferation,	  while	  poor	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cell	   attachment	  with	   rounded	  morphology	   commonly	   results	   in	   reduced	   viability	   19.	   Accordingly,	  GHPA	   readily	   supported	   MSC	   cell	   attachment	   likely	   through	   the	   RGD	   binding,	   and	   most	   MSCs	  underwent	   clear	   cell	   spreading	   by	   day	   15.	   Therefore,	   it	   is	   possible	   that	   this	   high	   level	   of	   cell	  attachment	  and	  spreading	  in	  crosslinked	  GHPA	  gels	  readily	  supported	  MSC	  proliferation.	  	  Most	   interesting	   results	   from	   the	   initial	   measurement	   of	   cell	   viability	   of	   MSCs	   were	   the	  changes	  in	  cell	  network	  organization	  over	  time.	  At	  day	  15,	  MSCs	  organized	  themselves	  into	  tubular	  networks	   that	   are	   typically	   seen	  with	   healthy	   endothelial	   cells	   on	   angiogenic	   substrates	   such	   as	  Matrigel.	   qRT-­‐PCR	   results	   revealed	   that	   endothelial	   cell	   markers	   (CD31	   and	   Flk-­‐1)	   were	   indeed	  significantly	  up-­‐regulated	  on	  day	  15,	  and	  MSC	  differentiation	  towards	  the	  endothelial	   lineage	  was	  further	  confirmed	  by	  LacZ	  expression	  in	  Flk-­‐1-­‐LacZ	  transgenic	  MSCs.	  Many	  studies	  have	  previously	  shown	  MSC	  differentiation	  into	  endothelial	  cells	  in	  vitro	  using	  soluble	  factors	  such	  as	  VEGF	  and/or	  bFGF	   as	   well	   as	   in	   vivo	   1a	   20	   21.	   However,	   to	   our	   knowledge,	   this	   is	   the	   first	   reporting	   of	   MSC	  differentiation	   into	   an	   endothelial	   lineage	   purely	   by	   material	   effects	   without	   the	   use	   of	   soluble	  growth	   factors.	   Existing	   literature	   shows	   that	   cell-­‐binding	   to	   the	   RGD	   sequence	   on	   gelatin	   or	  denatured	   collagen	   involves	   the	   activation	   of	   integrin	   αvβ3,	   which	   coincidentally	   is	   a	   crucial	  element	   in	  proliferation	  and	  migration/tubulogenesis	  of	   endothelial	   cells	   through	   its	   interactions	  with	   Flk-­‐1	   16	   22.	   In	   fact,	   blocking	   of	   αvβ3	   is	   an	   effective	   way	   to	   restrict	   angiogenesis,	   and	   is	  investigated	   as	   an	   anti-­‐cancer	   therapy,	   thus	   signifying	   the	   necessity	   and	   importance	   of	   αvβ3	   in	  angiogenesis	   23.	   Hence,	   it	   is	   possible	   that	   MSCs	   on	   our	   crosslinked	   GHPA	   gels	   are	   up-­‐regulating	  	  αvβ3	   expression	   and	   activation	   through	   the	  RGD	  binding,	   and	   the	   activated	   	   αvβ3	   then	   interacts	  with	  Flk-­‐1	  that	  was	  up-­‐regulated	  by	  an	  unknown	  mechanism.	  Considering	  the	   fact	   that	   the	  cross-­‐talk	   and	   interactions	   between	   αvβ3	   and	   Flk-­‐1	   are	   required	   to	   initiate	   the	   signaling	   cascade	   for	  proliferation	  and	  capillary	  formation	  of	  endothelial	  cells,	  a	  similar	  mechanism	  may	  be	  responsible	  for	   MSC	   differentiation	   and	   tubulogenesis	   as	   observed	   in	   this	   study	   22	   24.	   However,	   further	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investigation	   is	   needed	   to	   elucidate	   the	   exact	   mechanism	   of	   inducing	   endothelial	   differentiation	  from	  MSCs	  by	  crosslinked	  GHPA	  gels.	  	  	  	  The	  pro-­‐angiogenic	  effect	  of	  crosslinked	  GHPA	  gels	  was	  also	  shown	   in	  vivo.	  A	  multitude	  of	  assays	  was	   employed	   to	   confirm	   that	  when	   crosslinked	   GHPA	   gels	   delivered	  Flk-­‐1-­‐LacZ	   MSCs	   in	  porous,	   non-­‐biodegradable	   PVA	   scaffolds,	   functional	   angiogenesis	   was	   markedly	   promoted	  throughout	   the	  scaffolds	  after	  2	  weeks	  of	   subcutaneous	   implantation,	  while	   the	  control	   condition	  with	  non-­‐crosslinked	  GHPA	  had	  a	   limited	  degree	  of	   functional	  vascularization	  near	   the	  surface	  of	  the	  scaffold.	  Interestingly,	  there	  also	  appeared	  to	  be	  a	  positive	  correlation	  between	  the	  amount	  of	  neovasculature	  and	  the	  degree	  of	  GHPA	  content	  and	  crosslinking.	  This	   implies	  that	  the	  prolonged	  sustenance	  of	  GHPA	  gels	  in	  vivo	  may	  be	  a	  crucial	  factor	  in	  improving	  angiogenesis,	  as	  uncrosslinked	  gelatin	  is	  known	  to	  degrade	  rapidly	  in	  vivo	  by	  proteases	  such	  as	  matrix	  metalloproteinases	  (MMPs),	  and	   there	   was	   significantly	   less	   angiogenesis	   12.	   Therefore,	   without	   crosslinking	   the	   tubulogenic	  effect	  we	   observed	   in	   in	  vitro	   experiments	  was	   lost	   in	   the	   control	   condition,	  while	   the	   condition	  containing	   the	   most	   GHPA	   with	   the	   highest	   level	   of	   crosslinking	   showed	   the	   highest	   degree	   of	  angiogenesis.	  	  Only	  a	  very	  small	  number	  of	  studies	  investigated	  angiogenesis	  in	  thermally	  and	  chemically	  crosslinked	   gelatin	   implants	   using	   Gelfoam®	  that	   is	   commercially	   and	   clinically	   available.	   These	  studies	  showed	  significant	  angiogenesis	  in	  the	  implants	  when	  implanted	  alone	  25	  26.	  Interestingly,	  it	  was	  also	  shown	  that	  crosslinked	  gelatin	  scaffolds	  promoted	  angiogenesis	  significantly	  better	   than	  similarly	  prepared	  collagen	  scaffolds	   25.	  Our	  study	   is	  also	   in	  support	  of	   the	   in	  vivo	  pro-­‐angiogenic	  effect	  of	  crosslinked	  gelatin,	  however,	  our	  results	  are	  convoluted	  by	  the	  use	  of	  MSCs.	  Therefore,	  the	  angiogenic	   effect	   of	   crosslinked	   gelatin	   material	   alone	   and	   especially	   comparisons	   to	   other	  materials	  need	  to	  be	  investigated	  further.	  	  Another	  important	  advantage	  of	  gelatin	  material	  is	  its	  non-­‐immuno/antigenicity	  in	  vivo,	  as	  the	   harsh	   gelatin	   extraction	   process	   is	   thought	   to	   remove	   known	   antigens	   existing	   on	   intact	   3D	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collagen	  27.	  Injections	  of	  unmodified	  gelatin	  into	  several	  animals	  also	  failed	  to	  produce	  antibodies	  28.	  On	   the	   other	   hand,	   the	   abovementioned	   studies	   involving	   crosslinked	   gelatin	   sponges	   reported	  negligible	  inflammation	  and	  no	  scarring/fibrous	  capsule	  formation	  when	  implanted	  29	  25	  26.	  We	  also	  observed	   no	   giant	   foam	   cells	   or	   dense	   collagen	   deposition	   around	   the	   implanted	   GHPA	   gels.	  Furthermore,	  the	  gene	  expression	  profile	  revealed	  a	  significant	  increase	  in	  reparative	  macrophage	  recruitment,	   while	   there	   was	   a	   reduction	   in	   inflammatory	   macrophages	   in	   the	   highest	   GHPA	  content	   condition	  with	   the	  most	   crosslinking.	  Hence,	   the	  conjugation	  of	  hydroxyphenyl	  propionic	  acid	   to	   gelatin	   likely	   retains	   the	   non-­‐immuno/antigenicity	   of	   the	   unmodified	   gelatin,	   and	   highly	  crosslinked	   GHPA	   gel	   further	   invoked	   favorable	   interactions	   with	   host	   macrophages,	   which	   can	  forecast	  better	  long-­‐term	  integration	  with	  the	  host	  tissues.	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CHAPTER	  III	  
	  
CONCLUSION	  	   	  	   	  	  	  	  	  	  In	   this	   study,	  we	  have	  synthesized	  an	   injectable	  and	   in	  situ	   crosslinkable	  gelatin-­‐based	  biomaterial	   that	   was	   highly	   biocompatible	   and	   showed	   a	   marked	   pro-­‐angiogenic	   effect	   by	  promoting	   endothelial	   differentiation	   of	   MSCs	   both	   in	   vitro	   and	   in	   vivo.	   Crosslinked	   GHPA	   gels	  resulted	  in	  robust	  formation	  of	  neovasculature	  throughout	  the	  implants	  in	  coordination	  with	  non-­‐immuno/antigenicity	  and	  favorable	  macrophage	  responses.	  	  Of	  note,	  this	  is	  the	  first	  time	  to	  report	  that	  a	  material	  can	  induce	  MSC	  differentiation	  into	  an	  endothelial	  lineage	  without	  the	  use	  of	  soluble	  growth	   factors.	   The	   results	   are	   also	   highly	   significant	   as	   this	   is	   the	   first	   study	   to	   use	   a	   purely	  gelatin-­‐based	  material	  in	  a	  form	  of	  injectable	  hydrogel	  for	  vasculogenic	  delivery	  of	  stem	  cells	  in	  the	  fields	   of	   tissue	   engineering	   and	   regenerative	   medicine,	   which	   has	   been	   largely	   impossible	  previously.	   Because	   of	   the	   short	   history	   of	   using	   gelatin-­‐based	   materials	   in	   tissue	   engineering	  applications,	   the	   exact	   mechanisms	   for	   improved	   angiogenesis	   by	   crosslinked	   gelatin	   and	   3D	  gelatin-­‐cell	   interactions	  remain	  to	  be	  elucidated.	  Further	  studies	  are	  needed	  to	  better	  understand	  the	  apparent	  and	  numerous	  advantages	  of	  GHPA	  and	  its	  optimal	  applications	  in	  specific	  biomedical	  fields.	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